[Allogeneic umbilical cord blood transplantation in overweight patients: evaluation of outcome, alloreactivity and morbidity. Preliminary results of a phase I study]

Sangre (Barc). 1997 Apr;42(2):123-33.
[Article in Spanish]
No abstract available

Publication types

  • Case Reports
  • Clinical Trial
  • Clinical Trial, Phase I

MeSH terms

  • Acute Disease
  • Adolescent
  • Adult
  • Anemia, Aplastic / complications
  • Anemia, Aplastic / therapy
  • Blood Cell Count
  • Fanconi Anemia / complications
  • Fatal Outcome
  • Female
  • Fetal Blood / cytology*
  • Graft Survival
  • HLA Antigens / immunology
  • Hematopoietic Stem Cell Transplantation* / adverse effects
  • Hematopoietic Stem Cells / immunology
  • Histocompatibility
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy
  • Leukemia, Myeloid / complications
  • Leukemia, Myeloid / therapy
  • Obesity* / complications
  • Pilot Projects
  • Treatment Outcome

Substances

  • HLA Antigens